August 18, 2019

Statement from Sundial

Sundial is aware of an online article involving a commercial relationship with another Licensed Producer. There were factual inaccuracies in the article. While Sundial cannot comment on specific customer agreements due to contractual confidentiality, we can confirm that this isolated immaterial matter is being resolved between Sundial and the Licensed Producer. There is no impact on Q2 financial reporting and we anticipate that the impact on Q3 earnings will be negligible. Sundial follows strict Good Production Practices (GPP) in accordance with all Health Canada standards. Our company also uses standard provisions for potential returns which is consistent with industry practice.

Sundial is committed to producing safe, innovative and high-quality products.

Latest News

View All

Wednesday, Nov 13, 2019

Sundial Delivers Quarterly Net Revenue of $33.5 Million Representing 74% Sequential Growth

Sundial Delivers Quarterly Net Revenue of $33.5 Million Representing 74% Sequential Growth

Read More

Friday, Nov 08, 2019

Sundial Growers Announces Date and Time Changes for Third Quarter 2019 Earnings Call and Webcast

Sundial has announced that it has changed the time for its third quarter 2019 earnings conference call and webcast.

Read More

Thursday, Nov 07, 2019

Sundial Added to the NYSE-Listed “The Cannabis ETF”

Sundial is pleased to announce that it has been added to The Cannabis ETF, which trades on the New York Stock Exchange (NYSE).

Read More
image/svg+xml logo logo Created with Sketch.


Thanks, but unfortunately you need to be legal age to view our website.


You need to be of legal age to view our website.

Please choose a province and enter your date of birth to continue.


Date of Birth

By entering this site you agree to our